Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-47542-5, published online 30 July 2019
This Article contains an error. The p-mTORC1 control panel in Figure 8G was inadvertently duplicated from the p-Akt1 control panel in Figure 6C. The correct panels for Figure 8G and 8H appear below in Figure 1, as Panels 1A and 1B respectively. The statistical analyses were re-calculated for the m-TORC1 data, and the conclusions were unaffected.
Rapamycin enhanced early AVF remodeling to improve patency. (A) Photomicrographs of representative dual IF of a-actin (green) and p-Akt1 (red, first row) or p-mTORC1 (red, second row) in AVF after control, early or late rapamycin treatment (day 42). (B) Bar graphs showing quantification of dual IF in AVF after control, early rapamycin or late rapamycin treatment (day 42); p-Akt1-α-actin: p = 0.6067 (ANOVA); p-mTORC1-α-actin: *p = 0.0004 (ANOVA); control vs late rapamycin: p = 0.0016; n=5 for all groups except n = 4 in control group for p-mTORC1-α-actin.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Guo, X., Fereydooni, A., Isaji, T. et al. Author Correction: Inhibition of the Akt1-mTORC1 Axis Alters Venous Remodeling to Improve Arteriovenous Fistula Patency. Sci Rep 10, 8301 (2020). https://doi.org/10.1038/s41598-020-65540-w
Published:
DOI: https://doi.org/10.1038/s41598-020-65540-w
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
